Skip to content
Review

PD-1⁺ CD8⁺ T cells: roles of PD-1 beyond an exhaustion marker

Jul 2026 · Seminars in Immunopathology · Vol 48 · 0 citations · 104 references
Medicine

TL;DR

This review explores the multidimensional regulatory roles of PD-1 in CD8⁺ T cells, with a focus on elucidating the diverse functions and clinical significance of PD-1⁺CD8⁺ T cells in cancer, chronic infections, and autoimmune diseases.

View source

Similar papers

Review Open access Aug 2026

Programmed cell death-1: from a T-cell immune checkpoint to a regulator of Natural Killer cell biology

Programmed cell death protein 1 (PD-1, CD279) is a pivotal inhibitory immune checkpoint receptor that plays a central role in maintaining immune homeostasis and peripheral tolerance. Originally characterized as a negative regulator of T-cell activation, PD-1 limits excessive immune responses and prevents autoimmunity,...

Fabiana De Franco, Marco Greppi, Valentina Obino et al. · 0 citations
Review Open access Aug 2026

Stem-like CD4 T cells in tumors: an emerging framework for antitumor immunity

Recent studies have identified antigen-experienced TCF1+PD-1+ lineage-negative (lin-) CD4 T cells in several tumor types. Strictly, stemness requires durable self-renewal and multipotent output demonstrated at the single-cell level; these criteria have not yet been established for an individual tumor-associated CD4 T c...

Jia-Xiang Xu, Yun-Chao Yang, Jun Zhang et al. · 0 citations
Review Open access Jul 2026

Targeting the fate of exhausted CD8+ T cells.

This emerging view frames exhaustion as a context-dependent extension of the memory program rather than its collapse, and highlights how these insights can inform new approaches to manipulate T cell fate for therapeutic benefit.

Daniel T. Utzschneider, Stephen J. Turner · 0 citations
Review Aug 2026

PD-1+/PD-L1+macrophages across diseases: a translational continuum from biomarkers to immunotherapeutic targets.

Programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) are critical immune checkpoints that dynamically maintain the balance between immune tolerance and immune activation. Immune checkpoint blockade targeting the PD-1/PD-L1 axis can restore T cell-mediated antitumor immunity and has shown remarka...

Jinjing Wu, Dan Zhou, Kunpeng Jiang et al. · 0 citations
Open access Jul 2026

T cell differentiation drives programs of resistance to PD-1-mediated inhibition 2260353

Research into basic PD-1 biology, together with the clinical picture of cancer patients treated with PD-1 blockade, converge to emphasize that PD-1 engages complex signaling networks to support T cell homeostasis, differentiation and immune responses. However, there is a lack of comprehensive understanding in the...

Subhasree Sridhar, Woo-Seung Lee, E. Kanshin et al. · 0 citations
Open access Sep 2026

The Notch signaling pathway is a master regulator of CD8+ T cell exhaustion and differentiation during chronic infection

During chronic infection, the persistence of antigen and inflammation leads to the differentiation of CD8+ T cells into an exhausted state characterised by expression of inhibitory receptors (IRs) and the progressive loss of T cell functions. Among the different subsets of exhausted CD8+ T (Tex) cells, Tex progenitors...

Dave Maurice De Sousa, Salix Boulet, F. Duval et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.